Groundbreaking Research Urges Alzheimer’s Patients To Forget Everything They Know About Alzheimer’s

Story by Jacob Zlomke 

| Published Mar 30, 2010

The medical world changed in a big way on Friday, according to University of Michigan medical researcher Steve Kollwitz. With the aid of his crack medical team, Kollwitz orchestrated a major advancement in the research dedicated to finding a cure for Alzheimer’s disease, a brain disorder characterized by the slow onset of dementia and memory loss.

“In comparison to previous Alzheimer’s research, this discovery is a complete turnaround. In fact, I'd go as far to say that those suffering from the onset of it may as well forget everything they think they know about the disease,” Kollwitz said.

Kollwitz revealed the new treatment, which comes in the form of capsule medication as well as psychiatric therapy, will soon be up for testing and pending approval by the FDA. The drug is speculated to begin its trial runs in an estimated year, though if it meets the scrupulous standards set by the FDA, Kollwitz hopes the treatment will make its pharmaceutical debut in as little as nine months.

“At first, the trial runs will be completely preliminary,” FDA executive Margaret Hamburg said, “and will most likely focus on Alzheimer’s patients unaware that they actually have Alzheimer’s.”

“I don’t know very much about Alzheimer’s,” said Peggy Albrecht, 67, a Lincolnite who was consequently relocated to a rest home three years ago because of the disease. “I don’t even know how it affects me. All I know is that because of it, I’ve been in a rest home for ten whole minutes.”

Albrecht went on to express her excitement concerning the new treatment, “When the doctors first told me about it, they said that when thinking about the results of this new treatment, I should forget everything I know about Alzheimer’s. If that’s the case, then I think it’s already doing the tri — I've been in a rest home for 10 whole minutes.”